|
|
urogenital system development
|
GO:0001655 |
261 |
0.607
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.474
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.339
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.305
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.301
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.275
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.275
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.250
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.239
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.235
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.235
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.227
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.214
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.204
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.189
|
|
|
|
amino acid betaine transport
|
GO:0015838 |
3 |
0.182
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.182
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.179
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.179
|
|
|
|
carnitine transport
|
GO:0015879 |
3 |
0.178
|
|
|
|
cranial nerve development
|
GO:0021545 |
41 |
0.168
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.157
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.156
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.154
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.154
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.152
|
|
|
|
carnitine transmembrane transport
|
GO:1902603 |
3 |
0.143
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.143
|
|
|
|
metanephric dct cell differentiation
|
GO:0072240 |
3 |
0.134
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.133
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.131
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.131
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.130
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.128
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.123
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.120
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.120
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.120
|
|
|
|
regulation of kidney development
|
GO:0090183 |
40 |
0.119
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.118
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.117
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.111
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.110
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.109
|
|
|
|
amino acid betaine metabolic process
|
GO:0006577 |
7 |
0.108
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.106
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.106
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.103
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.103
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.102
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.096
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.095
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.094
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.094
|
|
|
|
amino acid transmembrane transport
|
GO:0003333 |
37 |
0.094
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.093
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.091
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.089
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.088
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.087
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.086
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.084
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.084
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.083
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.082
|
|
|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.078
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.076
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.076
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.074
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.073
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.072
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.071
|
Mouse |
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.071
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.070
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.070
|
|
|
|
carnitine metabolic process
|
GO:0009437 |
7 |
0.069
|
|
|
|
spinal cord oligodendrocyte cell fate specification
|
GO:0021530 |
3 |
0.068
|
|
|
|
spinal cord oligodendrocyte cell differentiation
|
GO:0021529 |
3 |
0.067
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.066
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.066
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.066
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.066
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.066
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.065
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.064
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.064
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.064
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.063
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.061
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.060
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.060
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.059
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.059
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.057
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.056
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.055
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.055
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.055
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.055
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.054
|
|
|
|
ventral spinal cord interneuron fate commitment
|
GO:0060579 |
14 |
0.054
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.053
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.053
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.052
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.051
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.051
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.050
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.050
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.050
|
|
|
|
spinal cord dorsal ventral patterning
|
GO:0021513 |
23 |
0.049
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.049
|
|
|
|
cell differentiation involved in kidney development
|
GO:0061005 |
33 |
0.049
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.049
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.049
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.049
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.047
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.047
|
|
|
|
regulation of thyroid hormone generation
|
GO:2000609 |
4 |
0.047
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.046
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.046
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.046
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.045
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.045
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.045
|
|
|
|
dct cell differentiation
|
GO:0072069 |
3 |
0.045
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.045
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.044
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.044
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.044
|
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.044
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.043
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.043
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.043
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.043
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.043
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.042
|
Mouse |
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.042
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.042
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.042
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.042
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.042
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.041
|
|
|
|
inorganic anion transmembrane transport
|
GO:0098661 |
29 |
0.041
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.040
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.040
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.040
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.039
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.039
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.039
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.039
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.039
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.039
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.039
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.039
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.039
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.039
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.038
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.038
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.038
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.038
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.038
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.037
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.037
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.037
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.037
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.037
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.036
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.036
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.036
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.036
|
|
|
|
cilium assembly
|
GO:0042384 |
81 |
0.036
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.035
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.035
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.035
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.035
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.035
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.035
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.035
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.034
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.034
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.034
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.034
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.034
|
|
|
|
cellular response to gonadotropin stimulus
|
GO:0071371 |
4 |
0.034
|
|
|
|
regulation of branching involved in ureteric bud morphogenesis
|
GO:0090189 |
22 |
0.034
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.034
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.034
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.033
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.033
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.033
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.033
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.033
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.033
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.033
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.033
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.033
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.033
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.032
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.032
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.032
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.032
|
|
|
|
positive regulation of thymocyte migration
|
GO:2000412 |
2 |
0.032
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.032
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.032
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.032
|
|
|
|
mechanoreceptor differentiation
|
GO:0042490 |
67 |
0.031
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.031
|
|
|
|
purkinje myocyte differentiation
|
GO:0003168 |
1 |
0.031
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.031
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.031
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.031
|
|
|
|
urate transport
|
GO:0015747 |
1 |
0.031
|
|
|
|
neuron fate specification
|
GO:0048665 |
30 |
0.030
|
|
|
|
ventral spinal cord interneuron fate determination
|
GO:0060580 |
1 |
0.030
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.030
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.030
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.030
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.030
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.030
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.030
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.030
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.030
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.030
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.030
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.029
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.029
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.029
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.029
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.029
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.029
|
|
|
|
plasma cell differentiation
|
GO:0002317 |
3 |
0.029
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.029
|
|
|
|
carbon catabolite repression of transcription from rna polymerase ii promoter
|
GO:0000437 |
1 |
0.029
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.029
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.028
|
|
|
|
forebrain neuron fate commitment
|
GO:0021877 |
13 |
0.028
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.028
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.028
|
|
|
|
intestinal epithelial cell maturation
|
GO:0060574 |
2 |
0.028
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.028
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.028
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.028
|
|
|
|
positive regulation of voltage gated calcium channel activity
|
GO:1901387 |
2 |
0.028
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.028
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.028
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.028
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.027
|
|
|
|
regulation of transcription from rna polymerase iii promoter
|
GO:0006359 |
2 |
0.027
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.027
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.027
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.027
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.027
|
Mouse |
|
|
ventricular compact myocardium morphogenesis
|
GO:0003223 |
2 |
0.027
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.027
|
|
|
|
regulation of cardioblast differentiation
|
GO:0051890 |
3 |
0.026
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.026
|
|
|
|
lung epithelium development
|
GO:0060428 |
37 |
0.026
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.026
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.026
|
|
|
|
hydrogen ion transmembrane transport
|
GO:1902600 |
25 |
0.026
|
|
|
|
hindbrain morphogenesis
|
GO:0021575 |
46 |
0.026
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.026
|
|
|
|
mesangial cell differentiation
|
GO:0072007 |
4 |
0.026
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
52 |
0.026
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.026
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.025
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.025
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.025
|
|
|
|
morphogenesis of an epithelial sheet
|
GO:0002011 |
27 |
0.025
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.025
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.025
|
|
|
|
organ induction
|
GO:0001759 |
21 |
0.025
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.025
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.025
|
|
|
|
succinate transmembrane transport
|
GO:0071422 |
1 |
0.025
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.024
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.024
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.024
|
|
|
|
ventral spinal cord development
|
GO:0021517 |
48 |
0.024
|
|
|
|
spinal cord patterning
|
GO:0021511 |
25 |
0.024
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.024
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.024
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.024
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.024
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.024
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.024
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.024
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.023
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.023
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.023
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.023
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.023
|
|
|
|
negative regulation of mesenchymal cell apoptotic process involved in metanephros development
|
GO:1900212 |
4 |
0.023
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.023
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.023
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.023
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.023
|
|
|
|
central nervous system projection neuron axonogenesis
|
GO:0021952 |
21 |
0.022
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.022
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.022
|
|
|
|
epithelial mesenchymal signaling involved in prostate gland development
|
GO:0060738 |
2 |
0.022
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.022
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.022
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.022
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.022
|
|
|
|
regulation of glial cell differentiation
|
GO:0045685 |
41 |
0.022
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.022
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.022
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.022
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.022
|
|
|
|
negative regulation of cell projection organization
|
GO:0031345 |
56 |
0.022
|
|
|
|
regulation of gliogenesis
|
GO:0014013 |
50 |
0.022
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.022
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.022
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.022
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.022
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.022
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.022
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.021
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.021
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.021
|
|
|
|
subpallium neuron fate commitment
|
GO:0060163 |
2 |
0.021
|
|
|
|
pyramidal neuron migration
|
GO:0021852 |
1 |
0.021
|
|
|
|
c4 dicarboxylate transport
|
GO:0015740 |
3 |
0.021
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.021
|
|
|
|
pancreatic pp cell differentiation
|
GO:0003312 |
2 |
0.021
|
|
|
|
columnar cuboidal epithelial cell development
|
GO:0002066 |
29 |
0.021
|
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.021
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.021
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.021
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.021
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.021
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.021
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.021
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.021
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
53 |
0.021
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.020
|
|
|
|
toxin transport
|
GO:1901998 |
38 |
0.020
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.020
|
|
|
|
nephrogenic mesenchyme development
|
GO:0072076 |
3 |
0.020
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.020
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.020
|
|
|
|
succinate transport
|
GO:0015744 |
1 |
0.020
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.020
|
|
|
|
metanephric nephron tubule epithelial cell differentiation
|
GO:0072257 |
5 |
0.020
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.020
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.020
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.020
|
|
|
|
cardiac pacemaker cell fate commitment
|
GO:0060927 |
1 |
0.020
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.020
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.020
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.020
|
|
|
|
modified amino acid transport
|
GO:0072337 |
5 |
0.020
|
|
|
|
striated muscle cell proliferation
|
GO:0014855 |
39 |
0.020
|
|
|
|
regulation of inositol phosphate biosynthetic process
|
GO:0010919 |
3 |
0.019
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.019
|
|
|
|
oligodendrocyte development
|
GO:0014003 |
20 |
0.019
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.019
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.019
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.019
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.019
|
|
|
|
glomerulus development
|
GO:0032835 |
40 |
0.019
|
|
|
|
positive regulation of thyroid hormone generation
|
GO:2000611 |
2 |
0.019
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.019
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.019
|
|
|
|
hypophysis morphogenesis
|
GO:0048850 |
3 |
0.019
|
|
|
|
olfactory bulb development
|
GO:0021772 |
30 |
0.019
|
|
|
|
forebrain regionalization
|
GO:0021871 |
25 |
0.019
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.019
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.019
|
|
|
|
dorsal ventral neural tube patterning
|
GO:0021904 |
28 |
0.019
|
|
|
|
negative regulation of apoptotic process involved in outflow tract morphogenesis
|
GO:1902257 |
2 |
0.019
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.019
|
|
|
|
positive regulation of kidney development
|
GO:0090184 |
28 |
0.019
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.019
|
|
|
|
sclerotome development
|
GO:0061056 |
4 |
0.019
|
|
|
|
energy coupled proton transmembrane transport against electrochemical gradient
|
GO:0015988 |
3 |
0.019
|
|
|
|
response to glycoside
|
GO:1903416 |
2 |
0.019
|
|
|
|
regulation of mesenchymal cell apoptotic process involved in metanephros development
|
GO:1900211 |
4 |
0.018
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.018
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.018
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.018
|
|
|
|
cerebral cortex radially oriented cell migration
|
GO:0021799 |
31 |
0.018
|
|
|
|
cd4 positive alpha beta t cell activation
|
GO:0035710 |
45 |
0.018
|
|
|
|
spinal cord motor neuron cell fate specification
|
GO:0021520 |
13 |
0.018
|
|
|
|
prostate gland stromal morphogenesis
|
GO:0060741 |
2 |
0.018
|
|
|
|
positive regulation of mesonephros development
|
GO:0061213 |
20 |
0.018
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.018
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.018
|
|
|
|
kidney rudiment formation
|
GO:0072003 |
3 |
0.018
|
|
|
|
metanephros morphogenesis
|
GO:0003338 |
24 |
0.018
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.018
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.018
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.018
|
|
|
|
neural tube patterning
|
GO:0021532 |
43 |
0.018
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.018
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.018
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.018
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.018
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.018
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.018
|
|
|
|
positive regulation of inositol phosphate biosynthetic process
|
GO:0060732 |
2 |
0.018
|
|
|
|
septum transversum development
|
GO:0003343 |
2 |
0.018
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.018
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.018
|
|
|
|
calcium independent cell cell adhesion via plasma membrane cell adhesion molecules
|
GO:0016338 |
4 |
0.018
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.018
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.017
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.017
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.017
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.017
|
|
|
|
inner ear receptor cell differentiation
|
GO:0060113 |
61 |
0.017
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.017
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.017
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.017
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.017
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.017
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.017
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.017
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.017
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.017
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.017
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.017
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.017
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.017
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.017
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.017
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.017
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.017
|
|
|
|
cellular amino acid catabolic process
|
GO:0009063 |
25 |
0.017
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.017
|
|
|
|
left right pattern formation
|
GO:0060972 |
23 |
0.017
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.017
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.017
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.017
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.017
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.017
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.017
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.017
|
|
|
|
renal capsule specification
|
GO:0072130 |
1 |
0.017
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.016
|
|
|
|
spleen development
|
GO:0048536 |
39 |
0.016
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.016
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.016
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.016
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.016
|
|
|
|
anatomical structure maturation
|
GO:0071695 |
49 |
0.016
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.016
|
|
|
|
positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis
|
GO:0072108 |
3 |
0.016
|
|
|
|
cardiac right atrium morphogenesis
|
GO:0003213 |
3 |
0.016
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.016
|
|
|
|
mammary gland lobule development
|
GO:0061377 |
22 |
0.016
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.016
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.016
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.016
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.016
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.016
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.016
|
|
|
|
regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000079 |
1 |
0.016
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.016
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.016
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.016
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.016
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.016
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.016
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.016
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.016
|
|
|
|
regulation of steroid biosynthetic process
|
GO:0050810 |
26 |
0.016
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.016
|
|
|
|
metanephric s shaped body morphogenesis
|
GO:0072284 |
2 |
0.016
|
|
|
|
pattern specification involved in metanephros development
|
GO:0072268 |
4 |
0.016
|
|
|
|
glandular epithelial cell differentiation
|
GO:0002067 |
38 |
0.015
|
|
|
|
response to osmotic stress
|
GO:0006970 |
21 |
0.015
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.015
|
|
|
|
lateral motor column neuron migration
|
GO:0097477 |
3 |
0.015
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.015
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.015
|
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.015
|
|
|
|
positive regulation of organ growth
|
GO:0046622 |
29 |
0.015
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.015
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.015
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.015
|
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.015
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.015
|
|
|
|
positive regulation of glial cell differentiation
|
GO:0045687 |
21 |
0.015
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.015
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.015
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.015
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.015
|
|
|
|
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development
|
GO:0060528 |
4 |
0.015
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.015
|
|
|
|
positive regulation of jnk cascade
|
GO:0046330 |
46 |
0.015
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.015
|
|
